ONXEO (EPA:ALONX) | Finanzwire

Basculer en Français

10963	Companies
239895	Keywords
168664	Articles
129057	Press releases

Home
Companies
ONXEO

BRIEF

published on 05/22/2024 at 20:51, 2 years 3 months ago

Valerio Therapeutics Advances VIO-01 Clinical Trial with Positive Results

Drug Development Solid Tumors Clinical Trial Valerio Therapeutics VIO-01
PRESS RELEASE

published on 05/22/2024 at 20:46, 2 years 3 months ago

Inside Information / Other news releases
Valerio Therapeutics completes dosing for first cohort of subjects in Phase 1/2 VIO-01 trial for solid tumors, showing encouraging tolerability. Phase 1b aims to determine recommended dose in selected solid tumors

Solid Tumors Valerio Therapeutics VIO-01 Trial Phase 1/2 DNA Damage Response
BRIEF

published on 04/30/2024 at 23:19, 2 years 4 months ago

Valerio Therapeutics Reports 2023 Fiscal Year Results and Clinical Updates

Biotechnology Clinical Trials Financial Results 2023 Valerio Therapeutics VIO-01
PRESS RELEASE

published on 04/30/2024 at 23:14, 2 years 4 months ago

Annual financial and audit reports / Terms of availability of the annual financial report
Valerio Therapeutics reports full year 2023 financial results and provides clinical development updates. The company's cash position is €6.8 million as of December 31, 2023, ensuring financial visibility until Q4 2024

Financial Results Cash Position 2023 Clinical Development Valerio Therapeutics

Accesswire

Published on 09/10/2026 at 17:46, 23 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 2 hours 49 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 3 hours 9 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 3 hours 32 minutes ago

Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/10/2026 at 14:30, 3 hours 39 minutes ago

Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference

View all ACCESSWIRE

EQS Group

Published on 09/10/2026 at 17:31, 38 minutes ago

NAGRAVISION Launches NAGRA® Venturi Agentic AI Integrated with Microsoft Azure to Strengthen Streaming Security
Published on 09/10/2026 at 17:20, 49 minutes ago

The World Is Taking Notice: TIME Recognition Fuels VinFast's Global Journey
Published on 09/10/2026 at 16:45, 1 hour 24 minutes ago

IPEC Successfully Holds NPO Standards Industry Summit, Aiming to Build a Robust International Standards Ecosystem
Published on 09/10/2026 at 16:39, 1 hour 30 minutes ago

UMT AG invites shareholders to an extraordinary general meeting: Change of name to WAYDEAR AG completes reorientation towards agentic AI
Published on 09/10/2026 at 16:20, 1 hour 49 minutes ago

MICROIP Secures Major US$20 Million Smart Residential Community Contract in Taiwan, Accelerating Edge AI Commercialization

Les Echos

Published on 09/10/2026 at 07:00, 11 hours 9 minutes ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 23 hours 24 minutes ago

Successful launch of a €500 million bond issue
Published on 09/09/2026 at 17:45, 1 day ago

Information concerning the total number of voting rights and shares 2026 08 31
Published on 09/09/2026 at 17:45, 1 day ago

Report on share repurchases from 7 to 8 September 2026
Published on 09/09/2026 at 17:45, 1 day ago

LANSON-BCC: H1 2026 results, A half-year marked by the integration of Champagne Heidsieck & C° Monopole

View all LES ECHOS COMFI WIRE